Cargando…
Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT)
Our aim was to assess the long-term clinical outcome of boron neutron capture therapy (BNCT) using (10)B-para-boronophenylalanine (BPA) as the boron delivery agent for cutaneous melanoma. Eight patients (eight lesions) were treated between October 2003 and April 2014. Their ages ranged from 48 to 86...
Autores principales: | Hiratsuka, Junichi, Kamitani, Nobuhiko, Tanaka, Ryo, Tokiya, Ryoji, Yoden, Eisaku, Sakurai, Yosinori, Suzuki, Minoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674695/ https://www.ncbi.nlm.nih.gov/pubmed/32990318 http://dx.doi.org/10.1093/jrr/rraa068 |
Ejemplares similares
-
Boron neutron capture therapy for vulvar melanoma and genital extramammary Paget’s disease with curative responses
por: Hiratsuka, Junichi, et al.
Publicado: (2018) -
Advances in Boron Neutron Capture Therapy (BNCT) for Recurrent Intracranial Meningioma
por: Lan, Tien-Li, et al.
Publicado: (2023) -
Imaging and profiling of absorbed doses in thermal neutron fields for Boron Neutron Capture Therapy (BNCT)
por: Gambarini, G, et al.
Publicado: (1999) -
RT-06 PLANNING OF BORON NEUTRON CAPTURE THERAPY (BNCT) USING POSITRON EMISSION TOMOGRAPHY (PET)
por: Kawabata, Shinji, et al.
Publicado: (2019) -
Organosilica nanoparticles containing sodium borocaptate (BSH) provide new prospects for boron neutron capture therapy (BNCT): efficient cellular uptake and enhanced BNCT efficacy
por: Laird, Mathilde, et al.
Publicado: (2023)